Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Oncotarget|January 30, 2016
Ki-67 is required for maintenance of cancer stem cells but not cell proliferationJustin Cidado, Hong Yuen Wong, D Marc Rosen, et al.
The Journal of Clinical Investigation|April 23, 2024
Oncogene-induced matrix reorganization controls CD8+ T cell function in the soft-tissue sarcoma microenvironmentAshley M Fuller, Hawley C Pruitt, Ying Liu, et al.
Journal of Hepatology|November 8, 2025
DNAJ-PKAc induces metabolic rewiring and enhanced glutamine flux in fibrolamellar HCCZeal Kamdar, Ethan Neumann, Kathryn Howe, et al.
Oncoimmunology|November 15, 2021
Implantation of a neoantigen-targeted hydrogel vaccine prevents recurrence of pancreatic adenocarcinoma after incomplete resectionDaniel Delitto, Daniel J Zabransky, Fangluo Chen, et al.
Cancer Immunology Research|June 26, 2026
Peripheral Th17 immune signature associates with excellent response to anti-PD1/anti-PD-L1 therapy across solid tumorsHoward L Li, Soren Charmsaz, Chester Kao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2014
Detection of cancer DNA in plasma of patients with early-stage breast cancerJulia A Beaver, Danijela Jelovac, Sasidharan Balukrishna, et al.
Journal for Immunotherapy of Cancer|April 21, 2026
Time-of-day of first checkpoint inhibitor dose influences clinical outcomes and immune responses in hepatocellular carcinomaHoward L Li, Soren Charmsaz, Benjamin J Reisman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2015
ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer PatientsDavid Chu, Costanza Paoletti, Christina Gersch, et al.
Nature Communications|April 21, 2025
Age-related divergence of circulating immune responses in patients with solid tumors treated with immune checkpoint inhibitorsChester Kao, Soren Charmsaz, Hua-Ling Tsai, et al.
Pageof 5